This blog looks into how peptides such as PTD-DBM, BPC-157, and GHK-Cu may support tissue repair and skin recovery
2,099.00 Regular price Rs
CJC-1295 Clinical Evidence The Foundation for GH Amplification In two randomised, placebo-controlled, double-blind clinical trials in healthy subjects aged 2161 years, subcutaneous administration of CJC-1295 produced dose-dependent increases in mean plasma GH concentrations of 2 to 10-fold for 6 days or more, and mean plasma IGF-1 concentrations of 1.5 to 3-fold for 911 days
Because MOTS-c enhances insulin-independent glucose uptake, patients with type 1 diabetes or those using exogenous insulin should be monitored carefully to prevent hypoglycemia, though this theoretical risk has not materialized in clinical reports to date
Flavour is yummy as well - doesn't taste artificial at all Published Thursday, 29 February 2024